
Moderna wants to extent its European footprint
According to the 10-year old biotech company local commercial presences are to be established in Belgium, Denmark, the Netherlands, Norway, Poland,...

Hansa Biopharma’s imlifidase advances to Phase III testing
According to Lund-based Hansa Biopharma AB the study protocol has been greenlighted both by the FDA and the European Medicines Agency (EMA), so its...

Catalent swallows VMIC Ltd
The biologics development and manufacturing facility taken over from Vaccine Manufacturing and Innovation Centre UK Ltd. is locaterd n to the south...

TargED Biopharmaceuticals BV raises €39m in Series A financing
Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures participated in the financing. Seed investors FIRST...

Finnish VTT spin-out Onego Bio Ltd raises €10m
Venture capital investors Agronomics Limited and Maki VC led the seed financing that is set to solve one of the most presssing environmental problems...

Join 900 US CEOs protest against Ukraine invasion
As Russia continues its unprovoked war on Ukraine, the U.S. life sciences community is united in its total rejection of the criminal actions taken by...

Meletios Therapeutics licences antiviral patent
Meletios has signed an exclusive license agreement with Institut Pasteur to commercialise Defective Viral Genomes (DVG). DVGs are truncated or...